Skip to main content
OpenTrials

Clinical trial condition

Skin Manifestations

Explore clinical trials studying Skin Manifestations. Study availability and eligibility vary by location and protocol.

1,076 public trials 160 recruiting studies
Refine in advanced search Browse all conditions

Skin Manifestations trial results

Recruiting

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

NCT07421167

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • DH Cancer Research Center LLC Margate, Florida, United States
  • Hope And Healing Care Hinsdale, Illinois, United States
View Trial Details
Recruiting

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

NCT06929299

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • North China University of Science and Technology Affiliated Hospital Tangshan, Hebei, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View Trial Details
Recruiting

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

NCT07194850

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +22 more
Locations
  • Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin Hopital des Enfants Bordeaux, France
  • Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK) Berlin, Germany
  • Gaslini Children's Hospital Genoa, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Italy
View all 21 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

NCT06979453

Conditions
Exanthema, Pathological Conditions, Signs and Symptoms, Plaque Psoriasis, +7 more
Locations
  • Local Institution - 0261 Birmingham, Alabama, United States
  • Local Institution - 0041 Birmingham, Alabama, United States
  • Local Institution - 0053 Phoenix, Arizona, United States
  • Local Institution - 0025 Fountain Valley, California, United States
View all 132 locations
View Trial Details
Recruiting

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

NCT07104565

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Palo Verde Cancer Specialists Palo Verde Hematology Oncology, Ltd Glendale Glendale, Arizona, United States
  • Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Rocky Mountain Cancer Centers Lone Tree, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
View all 40 locations
View Trial Details
Recruiting

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

NCT07059000

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California Los Angeles, California, United States
  • NY Cancer and Blood Specialists Shirley, New York, United States
  • East Carolina University Greenville, North Carolina, United States
  • Vseobecna Fakultni Nemocnice v Praze Prague, Czechia
View all 28 locations
View Trial Details

Related conditions